NCT02867033 2026-03-30
ALTITUDES
Centre Oscar Lambret
Phase NA Active not recruiting
Clinical Trials
20 trialsNCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT07401355 2026-02-10
LIGHT-CTC
Centre Leon Berard
Phase NA Not yet recruiting
NCT05890781 2026-02-09
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT04037527 2026-02-04
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Wake Forest University Health Sciences
Phase 1 Terminated
NCT01991379 2025-12-04
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT07058064 2025-10-15
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Mayo Clinic
Phase NA Recruiting
NCT06332274 2025-05-13
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT04025541 2025-04-02
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT04224064 2025-02-12
ESPACE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT04458792 2025-02-12
BCBSarcome
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT06385288 2024-12-06
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
University Hospital Tuebingen
Phase NA Recruiting
NCT05854966 2024-09-19
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT03375437 2024-08-26
RNASARC
Centre Leon Berard
Phase NA Active not recruiting
NCT03818412 2024-03-22
Circulating Tumor DNA in Soft Tissue Sarcoma
University Health Network, Toronto
Phase NA Unknown
NCT03860207 2023-09-13
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT03946943 2019-07-10
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
The First Hospital of Jilin University
Phase 2 Unknown
NCT01786889 2016-07-29
ANGIHE
Centre Oscar Lambret
Phase NA Unknown
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed